School of Psychology, The University of Auckland, Auckland, New Zealand.
Department of Disability Studies, University of Kelaniya, Colombo, Sri Lanka.
Int J Speech Lang Pathol. 2024 Aug;26(4):457-474. doi: 10.1080/17549507.2023.2215488. Epub 2023 Aug 3.
This systematic review evaluated the efficacy of therapeutic interventions on improving swallow, respiratory, and cough functions in Parkinson's disease (PD).
A PRISMA systematic search was implemented across six databases. We selected studies reporting pre- and post-assessment data on the efficacy of behavioural therapies with a swallow or respiratory/cough outcome, and excluded studies on medical/surgical treatments or single-session design. Cross-system outcomes across swallow, respiratory, and cough functions were explored. Cochrane's risk of bias tools were utilised to evaluate study quality.
Thirty-six articles were identified and further clustered into four treatment types: swallow related ( = 5), electromagnetic stimulation ( = 4), respiratory loading ( = 20), and voice loading ( = 7) therapies. The effects of some behavioural therapies were supported with high-quality evidence in improving specific swallow efficiency, respiratory pressure/volume, and cough measures. Only eleven studies were rated with a low risk of bias and the remaining studies failed to adequately describe blinding of assessors, missing data, treatment adherence, and imbalance assignment to groups.
Behavioural therapies were diverse in nature and many treatments demonstrated broad cross-system outcome benefits across swallow, respiratory, and cough functions. Given the progressive nature of the condition, the focus of future trials should be evaluating follow-up therapy effects and larger patient populations, including those with more severe disease.
本系统评价评估了治疗干预措施对改善帕金森病(PD)吞咽、呼吸和咳嗽功能的疗效。
在六个数据库中进行了 PRISMA 系统搜索。我们选择了报告行为疗法对吞咽或呼吸/咳嗽结果的疗效的预评估和后评估数据的研究,并排除了关于医疗/手术治疗或单次治疗设计的研究。探索了吞咽、呼吸和咳嗽功能的跨系统结局。使用 Cochrane 偏倚风险工具评估研究质量。
确定了 36 篇文章,并进一步分为四种治疗类型:与吞咽相关的治疗(= 5)、电磁刺激(= 4)、呼吸负荷(= 20)和声音负荷(= 7)治疗。一些行为疗法的效果具有高质量证据支持,可以改善特定的吞咽效率、呼吸压力/容量和咳嗽措施。只有 11 项研究被评为低偏倚风险,其余研究未能充分描述评估者的盲法、数据缺失、治疗依从性和组间不平衡分配。
行为疗法性质多样,许多治疗方法在吞咽、呼吸和咳嗽功能方面都显示出广泛的跨系统结局益处。鉴于该疾病的进行性性质,未来试验的重点应是评估随访治疗效果和更大的患者人群,包括病情更严重的患者。